1. Prophylactic application of an intra-alveolar socket medicament to reduce postextraction complications in HIV-seropositive patients.
- Author
-
Pankhurst CL, Lewis DA, and Clark DT
- Subjects
- Acquired Immunodeficiency Syndrome, Adult, Aspirin therapeutic use, Chlortetracycline therapeutic use, Dibucaine, Drug Combinations, Dry Socket etiology, Female, HIV Seropositivity, Humans, Male, Middle Aged, Surgical Wound Infection microbiology, Surgical Wound Infection prevention & control, Wound Healing, Anesthetics, Local therapeutic use, Dental Care for Chronically Ill methods, Dry Socket prevention & control, HIV Infections, Occlusive Dressings, Tetracaine, Tooth Extraction adverse effects
- Abstract
A prospective, controlled trial was performed to investigate the effect of a prophylactic socket medicament containing chlortetracycline, aspirin, and local anesthetics, in reducing the incidence of postextraction pain and infection in patients who are HIV-seropositive. Fifty patients were in the study; 25 received the experimental dressing and 25 had no dressing. Patients were asked to complete a questionnaire rating the pain at 24 hours and 48 hours after surgery. Seven days after extraction, socket healing was scored, and sockets with delayed healing sampled for culture. Four of 25 (16%) patients who received the experimental dressing and 8 of 25 (32%) controls experienced pain during the 48 hours after extraction (p = not significant). None of the group who received the experimental dressing and 7 of 25 (28%) in the control group had delayed healing, of these 4 had alveolar osteitis and three had infected sockets (p = 0.0096). We conclude that the experimental agent is useful as a prophylactic agent to reduce delayed healing in HIV-positive patients who undergo exodontia.
- Published
- 1994
- Full Text
- View/download PDF